Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

Estrogen deficiency can reduce the enzyme activity needed to activate vitamin D.

Ovarian hyperthecosis can cause high testosterone and symptoms like hair loss, and surgery can help improve these symptoms.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

An 80-year-old woman's severe hair loss was caused by a hormone-secreting ovarian tumor.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

A 22-year-old woman with a rare genetic condition was successfully treated to develop normal female characteristics and regular menstruation.